2023 Q1 Form 10-Q Financial Statement

#000147793223001521 Filed on March 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $10.78M $8.877M
YoY Change 21.41% 354.91%
Cost Of Revenue $8.335M $6.853M
YoY Change 21.62% 617.76%
Gross Profit $2.443M $2.024M
YoY Change 20.7% 103.1%
Gross Profit Margin 22.67% 22.8%
Selling, General & Admin $2.772M $1.600M
YoY Change 73.26% 70.21%
% of Gross Profit 113.47% 79.04%
Research & Development $20.21K
YoY Change -30.03%
% of Gross Profit 1.0%
Depreciation & Amortization $9.897K $96.70K
YoY Change -89.77%
% of Gross Profit 0.41% 4.78%
Operating Expenses $2.772M $1.620M
YoY Change 71.1% 67.57%
Operating Profit -$329.0K $404.0K
YoY Change -181.43% 1257.57%
Interest Expense $998.00 $0.00
YoY Change -100.0%
% of Operating Profit 0.0%
Other Income/Expense, Net $31.12K $85.12K
YoY Change -63.44%
Pretax Income -$297.8K $489.1K
YoY Change -160.9% 878.16%
Income Tax $145.7K $75.40K
% Of Pretax Income 15.42%
Net Earnings -$443.5K $413.7K
YoY Change -207.22% 693.11%
Net Earnings / Revenue -4.12% 4.66%
Basic Earnings Per Share -$0.01 $0.01
Diluted Earnings Per Share -$0.01 $0.01
COMMON SHARES
Basic Shares Outstanding 35.57M shares 27.75M shares
Diluted Shares Outstanding 33.31M shares

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.42M $15.24M
YoY Change 1.19% 30.16%
Cash & Equivalents $15.42M $15.24M
Short-Term Investments
Other Short-Term Assets $332.3K $167.2K
YoY Change 98.73% -59.21%
Inventory $1.613M $851.7K
Prepaid Expenses $274.7K $109.8K
Receivables $3.490M $1.709M
Other Receivables $0.00 $0.00
Total Short-Term Assets $21.21M $18.50M
YoY Change 14.65% 33.95%
LONG-TERM ASSETS
Property, Plant & Equipment $78.48K $30.52K
YoY Change 157.16%
Goodwill $10.38M $10.72M
YoY Change -3.15%
Intangibles $2.569M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.17M $13.63M
YoY Change -3.39%
TOTAL ASSETS
Total Short-Term Assets $21.21M $18.50M
Total Long-Term Assets $13.17M $13.63M
Total Assets $34.38M $32.13M
YoY Change 7.0% 132.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.098M $1.208M
YoY Change 73.74% 1409.69%
Accrued Expenses $602.5K $688.0K
YoY Change -12.43%
Deferred Revenue $1.367M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.829M $4.413M
YoY Change -13.23% 698.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $37.73K $144.3K
YoY Change -73.84%
Total Long-Term Liabilities $37.73K $144.2K
YoY Change -73.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.829M $4.413M
Total Long-Term Liabilities $37.73K $144.2K
Total Liabilities $3.867M $4.557M
YoY Change -15.15% 724.67%
SHAREHOLDERS EQUITY
Retained Earnings -$25.12M -$24.08M
YoY Change 4.33% -3.98%
Common Stock $361.00 $280.00
YoY Change 28.93% 23.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 666.3K shares 70.33K shares
Shareholders Equity $30.52M $27.58M
YoY Change
Total Liabilities & Shareholders Equity $34.38M $32.13M
YoY Change 7.0% 132.62%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$443.5K $413.7K
YoY Change -207.22% 693.11%
Depreciation, Depletion And Amortization $9.897K $96.70K
YoY Change -89.77%
Cash From Operating Activities $401.7K $1.841M
YoY Change -78.19% 2231.95%
INVESTING ACTIVITIES
Capital Expenditures $60.92K -$53.87K
YoY Change -213.09%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$3.341M
YoY Change -100.0%
Cash From Investing Activities -$60.92K -$3.395M
YoY Change -98.21% -1768494.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 $200.00
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities $401.7K $1.841M
Cash From Investing Activities -$60.92K -$3.395M
Cash From Financing Activities $0.00 $200.00
Net Change In Cash $474.2K -$1.555M
YoY Change -130.49% -123.23%
FREE CASH FLOW
Cash From Operating Activities $401.7K $1.841M
Capital Expenditures $60.92K -$53.87K
Free Cash Flow $340.7K $1.895M
YoY Change -82.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3828963 usd
CY2022Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
235246 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
52577 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
137889 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
182444 usd
CY2023Q1 gmgi Contingent Liability
ContingentLiability
615839 usd
CY2022Q4 gmgi Contingent Liability
ContingentLiability
573197 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001437925
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28182575 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36099526 shares
CY2023Q1 gmgi Preferred Shares
PreferredShares
0 shares
CY2023Q1 gmgi Warrants Options
WarrantsOptions
0 shares
CY2022Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2021Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
us-gaap Revenues
Revenues
9333492 usd
CY2021 us-gaap Revenues
Revenues
5223059 usd
us-gaap Revenues
Revenues
1758599 usd
us-gaap Revenues
Revenues
11285731 usd
CY2021 us-gaap Revenues
Revenues
11285731 usd
us-gaap Net Income Loss
NetIncomeLoss
648072 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
398080 usd
us-gaap Net Income Loss
NetIncomeLoss
966774 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1525091 usd
CY2021 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2248877 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1087816 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1112986 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
566593 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
149177 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
66666 shares
CY2023Q1 gmgi Cash Exercised
CashExercised
66666 shares
CY2023Q1 gmgi Aggregate Exercise Price
AggregateExercisePrice
32000 usd
CY2022Q3 gmgi Aggregate Restricted Units
AggregateRestrictedUnits
1575000 shares
CY2018Q1 gmgi Common Stock Shares Issued1
CommonStockSharesIssued1
5400000 shares
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6050508 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2000052 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
57224 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
602628 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
324147 usd
CY2023Q1 gmgi Income Tax Expense Benefits
IncomeTaxExpenseBenefits
419049 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41326
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Golden Matrix Group, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1814729
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3651 Lindell Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Ste D131
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89103
CY2023Q1 dei City Area Code
CityAreaCode
702
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
318-7548
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 Par Value Per Share
CY2023Q1 dei Trading Symbol
TradingSymbol
GMGI
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36099526 shares
CY2023Q1 us-gaap Deposit Assets
DepositAssets
57630 usd
CY2023Q1 gmgi Consideration Payable
ConsiderationPayable
30708 usd
CY2022Q4 gmgi Consideration Payable
ConsiderationPayable
0 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
30708 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2715154 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37733 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59778 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
37733 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
59778 usd
CY2023Q1 us-gaap Liabilities
Liabilities
3866696 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2774932 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36099526 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28182575 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
361 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
282 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
55690495 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51677727 usd
CY2023Q1 gmgi Unearned Compensation
UnearnedCompensation
-2611 usd
CY2022Q4 gmgi Unearned Compensation
UnearnedCompensation
0 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-53488 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-205747 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25118368 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24674847 usd
CY2023Q1 gmgi Shareholders Equity Of Gmgi
ShareholdersEquityOfGmgi
30516389 usd
CY2022Q4 gmgi Shareholders Equity Of Gmgi
ShareholdersEquityOfGmgi
26797415 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
0 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
2999066 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30516389 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29796481 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34383085 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32571413 usd
CY2023Q1 gmgi Revenues1
Revenues1
10591036 usd
CY2022Q1 gmgi Revenues1
Revenues1
8641859 usd
CY2023Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
186643 usd
CY2022Q1 us-gaap Revenues
Revenues
8877105 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
2443034 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2037295 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1464545 usd
CY2023Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
734694 usd
CY2022Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
155600 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2771989 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1620145 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-328955 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
403958 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
998 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11905 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
441 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
20213 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
84676 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31120 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
85117 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-297835 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
489075 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75404 usd
CY2023Q1 gmgi Net Income Attributable To Noncontrolling Interest1
NetIncomeAttributableToNoncontrollingInterest1
0 usd
CY2022Q1 gmgi Net Income Attributable To Noncontrolling Interest1
NetIncomeAttributableToNoncontrollingInterest1
64292 usd
CY2023Q1 gmgi Net Income Attributable To Gmgi
NetIncomeAttributableToGmgi
-443521 usd
CY2022Q1 gmgi Net Income Attributable To Gmgi
NetIncomeAttributableToGmgi
349379 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
33311667 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
27747956 shares
CY2023Q1 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
33311667 shares
CY2022Q1 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
35758682 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 gmgi Net Income
NetIncome
-443521 usd
CY2022Q1 gmgi Net Income
NetIncome
413671 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
152259 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
57054 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-291262 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
470725 usd
CY2023Q1 gmgi Net Income Attributable To Noncontrolling Interest
NetIncomeAttributableToNoncontrollingInterest
0 usd
CY2022Q1 gmgi Net Income Attributable To Noncontrolling Interest
NetIncomeAttributableToNoncontrollingInterest
64292 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-291262 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
406433 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
18928109 usd
CY2022Q1 gmgi Shares Issued For Services Amount
SharesIssuedForServicesAmount
6000 usd
CY2022Q1 gmgi Shares Issued On Cashless Exercise Of Options Amount
SharesIssuedOnCashlessExerciseOfOptionsAmount
0 usd
CY2022Q1 gmgi Shares Issued On Cashless Exercise Of Options Related Party Amount
SharesIssuedOnCashlessExerciseOfOptionsRelatedPartyAmount
0 usd
CY2022Q1 gmgi Shares Issued As Consideration To Acquire Rkings Amount
SharesIssuedAsConsiderationToAcquireRkingsAmount
5330000 usd
CY2022Q1 gmgi Fv Of Option Warrants Issued For Services
FvOfOptionWarrantsIssuedForServices
137931 usd
CY2022Q1 gmgi Cumulative Translation Adjustment
CumulativeTranslationAdjustment
57054 usd
CY2022Q1 gmgi Fair Value Of Non Controlling Interest In Rkings
FairValueOfNonControllingInterestInRkings
2705000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
413671 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
27577765 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29796481 usd
CY2023Q1 gmgi Shares Issued As Consideration To Acquire Rkings Amount
SharesIssuedAsConsiderationToAcquireRkingsAmount
0 usd
CY2023Q1 gmgi Shares Issued On Cashless Exercise Of Options Amount
SharesIssuedOnCashlessExerciseOfOptionsAmount
0 usd
CY2023Q1 gmgi Shares Issued For Services Amount
SharesIssuedForServicesAmount
263389 usd
CY2023Q1 gmgi Shares Issued For Vested Rsus Amount
SharesIssuedForVestedRsusAmount
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
818395 usd
CY2023Q1 gmgi Cumulative Translation Adjustment
CumulativeTranslationAdjustment
152259 usd
CY2023Q1 gmgi Adjustment To Reduce Nci Amount Recorded For Rkings Acquisition
AdjustmentToReduceNciAmountRecordedForRkingsAcquisition
-70614 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-443521 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30516389 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-443521 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
413671 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
818395 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
137931 usd
CY2023Q1 gmgi Fair Value Of Shares Issued For Services2
FairValueOfSharesIssuedForServices2
263389 usd
CY2022Q1 gmgi Fair Value Of Shares Issued For Services2
FairValueOfSharesIssuedForServices2
6000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
42642 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
106666 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
94169 usd
CY2023Q1 us-gaap Depreciation
Depreciation
9897 usd
CY2022Q1 us-gaap Depreciation
Depreciation
2532 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-820054 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39998 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
58358 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
773290 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6601 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-950 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-378170 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36352 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
23993 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
24100 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
626252 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
126983 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
17767 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
4378 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
145686 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
75404 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-55912 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
122634 usd
CY2023Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
3642 usd
CY2022Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
7830 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-23978 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-22923 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
401653 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1841399 usd
CY2023Q1 gmgi Cash Paid For Purchase Of Rkings
CashPaidForPurchaseOfRkings
0 usd
CY2022Q1 gmgi Cash Paid For Purchase Of Rkings
CashPaidForPurchaseOfRkings
-3341453 usd
CY2023Q1 gmgi Cash Paid For Leasehold Improvement
CashPaidForLeaseholdImprovement
-6202 usd
CY2022Q1 gmgi Cash Paid For Leasehold Improvement
CashPaidForLeaseholdImprovement
0 usd
CY2023Q1 gmgi Cash Paid For Purchase Of Fixed Assets
CashPaidForPurchaseOfFixedAssets
-1933 usd
CY2022Q1 gmgi Cash Paid For Purchase Of Fixed Assets
CashPaidForPurchaseOfFixedAssets
-5992 usd
CY2023Q1 gmgi Cash Paid For Purchase Of Intangible Assets
CashPaidForPurchaseOfIntangibleAssets
-52788 usd
CY2022Q1 gmgi Cash Paid For Purchase Of Intangible Assets
CashPaidForPurchaseOfIntangibleAssets
-47873 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60923 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3395318 usd
CY2023Q1 gmgi Advance From Shareholders
AdvanceFromShareholders
0 usd
CY2022Q1 gmgi Advance From Shareholders
AdvanceFromShareholders
200 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
200 usd
CY2023Q1 gmgi Effect Of Exchange Rates On Cash And Cash Equivalents
EffectOfExchangeRatesOnCashAndCashEquivalents
133494 usd
CY2022Q1 gmgi Effect Of Exchange Rates On Cash And Cash Equivalents
EffectOfExchangeRatesOnCashAndCashEquivalents
-1671 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
474224 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1555390 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14949673 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16797656 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15423897 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15242266 usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
998 usd
CY2022Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 gmgi Cashless Exercise Of Options
CashlessExerciseOfOptions
71 usd
CY2022Q1 gmgi Cashless Exercise Of Options
CashlessExerciseOfOptions
1 usd
CY2023Q1 gmgi Intangible Asset Written Down
IntangibleAssetWrittenDown
0 usd
CY2022Q1 gmgi Intangible Asset Written Down
IntangibleAssetWrittenDown
58000 usd
CY2023Q1 gmgi Acquisition Of20 Shares Of Rkings
AcquisitionOf20SharesOfRkings
488060 usd
CY2022Q1 gmgi Acquisition Of20 Shares Of Rkings
AcquisitionOf20SharesOfRkings
0 usd
CY2021Q4 gmgi Stockholders Equity Reverse Stock Split1
StockholdersEquityReverseStockSplit1
authorized number of shares of Common Stock from forty million (40,000,000) shares to two hundred and fifty million (250,000,000) shares and to restate Article 3, Capital Stock thereof
CY2022Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2023Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include contingent liability, stock-based compensation, warrant valuation, accrued expenses and collectability of accounts receivable. The Company evaluates its estimates on an on-going basis and bases its estimates on historical experience and on various other assumptions the Company believes to be reasonable. Due to inherent uncertainties, actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2023Q1 us-gaap Development Costs
DevelopmentCosts
52788 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1612975 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1147591 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78484 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72411 usd
CY2023Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
106666 usd
CY2022Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
94169 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-443521 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
349379 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33311667 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27747956 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 gmgi Net Income Available To Common Shareholders
NetIncomeAvailableToCommonShareholders
-443521 usd
CY2022Q1 gmgi Net Income Available To Common Shareholders
NetIncomeAvailableToCommonShareholders
349379 usd
CY2023Q1 gmgi Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
33311667 shares
CY2022Q1 gmgi Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
27747956 shares
CY2022Q1 gmgi Preferred Shares
PreferredShares
1000 shares
CY2022Q1 gmgi Warrants Options
WarrantsOptions
7939394 shares
CY2022Q1 gmgi Consideration Payable One
ConsiderationPayableOne
70332 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
33311667 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
35758682 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q4 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
413714 usd
CY2022Q4 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
661773 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
82722 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
8.00
CY2022Q4 gmgi Aggregate Shares Of Common Stock
AggregateSharesOfCommonStock
165444 shares
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3489673 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2641023 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q1 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
355356 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
274688 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
84372 usd
CY2023Q1 us-gaap Other Inventory Supplies
OtherInventorySupplies
211202 usd
CY2022Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
70156 usd
CY2023Q1 gmgi Prepayment For The Gaming License Fee
PrepaymentForTheGamingLicenseFee
57114 usd
CY2022Q4 gmgi Prepayment For The Gaming License Fee
PrepaymentForTheGamingLicenseFee
8744 usd
CY2023Q1 gmgi Prepaid Payroll Expense
PrepaidPayrollExpense
6372 usd
CY2022Q4 gmgi Prepaid Payroll Expense
PrepaidPayrollExpense
5472 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
274688 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
84372 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
140153 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
150653 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
107050 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
95085 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37733 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59778 usd
CY2023Q1 gmgi Cash Payment
CashPayment
4099500 usd
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
666250 shares
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Interest Acquired1
NoncashOrPartNoncashAcquisitionInterestAcquired1
0.80 pure
CY2022Q4 gmgi Equity Ownership Percentage
EquityOwnershipPercentage
1 pure
CY2023Q1 gmgi Schedule Of Cash Consideration Policytext Block
ScheduleOfCashConsiderationPolicytextBlock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Consideration paid for RKings</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Closing cash consideration of GBP £3,000,000 based on Exchange Rate on November 1, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,099,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value of 666,250 restricted shares consideration at $7.60 per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,063,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value of contingent shares consideration for net assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">562,650</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Holdback amount paid to Mr. Mark Weir</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">683,250</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value of 165,444 restricted shares at $2.95 per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">488,060</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Consideration paid through January 31, 2023 </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>10,896,960</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q1 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
0.20 pure
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2705000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
106666 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
94169 usd
CY2023Q1 gmgi Accumulated Amortization
AccumulatedAmortization
531541 usd
CY2022Q4 gmgi Accumulated Amortization
AccumulatedAmortization
442479 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3100060 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3029554 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-531541 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-422479 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2568519 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2607075 usd
CY2023Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
28941 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
10637 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
137889 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
182444 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
All shares and prices per share have been adjusted for a 1 share-for-150 shares reverse stock split that took effect on June 26, 2020
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7333332 shares
CY2023Q1 gmgi Aggregate Price
AggregatePrice
211102 usd
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
132525 usd
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
137931 usd
CY2022Q4 gmgi Outstanding Options Beginning Balance
OutstandingOptionsBeginningBalance
8426666 shares
CY2022Q4 gmgi Weighted Average Exercise Price Beginning Balance
WeightedAverageExercisePriceBeginningBalance
0.50
CY2023Q1 gmgi Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod
7333332 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.07
CY2023Q1 gmgi Outstanding Options Ending Balance
OutstandingOptionsEndingBalance
1093334 shares
CY2023Q1 gmgi Weighted Average Exercise Price Ending Balance
WeightedAverageExercisePriceEndingBalance
3.41
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
843334 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.86
CY2023Q1 gmgi Schedule Of Grant And Vesting Of Restricted Stock Units Table Textblock
ScheduleOfGrantAndVestingOfRestrictedStockUnitsTableTextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Recipient</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Position with Company</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of RSUs</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Anthony Brian Goodman</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:60%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">President, Chief Executive Officer (Principal Executive Officer), Secretary, Treasurer, and Chairman of the Board of Directors</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">750,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weiting ‘Cathy’ Feng </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Chief Operating Officer and Director of the Company</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">375,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Murray G. Smith </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Independent Director</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">150,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Aaron Richard Johnston</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Independent Director</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">150,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thomas E. McChesney</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Independent Director</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">150,000</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>1,575,000</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
1575000 shares
CY2023Q1 gmgi Schedule Of Performance Metrics Table Textblock
ScheduleOfPerformanceMetricsTableTextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="5" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Revenue Targets</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="5" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>EBITDA Targets</strong></p></td><td style="width:1%;"> </td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Performance Period</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Target Goal</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>RSUs Vested</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Target Goal</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>RSUs Vested</strong></p></td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Year ended October 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">21,875,000</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3,250,000</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Year ended October 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">FY 2022 x 1.1</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">FY 2022 x 1.1</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Year ended October 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">FY 2023 x 1.1</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">FY 2023 x 1.1</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="width:1%;"> </td></tr></tbody></table>
CY2023Q1 us-gaap Revenues
Revenues
10777679 usd
CY2023Q1 gmgi Revenue Percentage Of Total Revenue
RevenuePercentageOfTotalRevenue
1 pure
CY2022Q1 us-gaap Revenues
Revenues
8877105 usd
CY2022Q1 gmgi Revenue Percentage Of Total Revenue
RevenuePercentageOfTotalRevenue
1 pure
CY2023Q1 us-gaap Revenues
Revenues
10777679 usd
CY2023Q1 gmgi Revenue Percentage Of Total Revenue
RevenuePercentageOfTotalRevenue
1 pure
CY2022Q1 us-gaap Revenues
Revenues
8877105 usd
CY2022Q1 gmgi Revenue Percentage Of Total Revenue
RevenuePercentageOfTotalRevenue
1 pure
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8334645 usd
CY2023Q1 gmgi Cost Of Goods Sold Percentage
CostOfGoodsSoldPercentage
1 pure
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6853002 usd
CY2022Q1 gmgi Cost Of Goods Sold Percentage
CostOfGoodsSoldPercentage
1 pure
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8334645 usd
CY2023Q1 gmgi Cost Of Goods Sold Percentage
CostOfGoodsSoldPercentage
1 pure
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6853002 usd
CY2022Q1 gmgi Cost Of Goods Sold Percentage
CostOfGoodsSoldPercentage
1 pure
CY2023Q1 us-gaap Noncurrent Assets
NoncurrentAssets
13168866 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
13282463 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
602628 usd
CY2023Q1 gmgi Income Tax Expenses Benefit1
IncomeTaxExpensesBenefit1
145686 usd
CY2023Q1 gmgi Income Taxe Paid
IncomeTaxePaid
-549697 usd
CY2023Q1 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
-122358 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
495308 usd

Files In Submission

Name View Source Status
gmgi-20230131_lab.xml Edgar Link unprocessable
gmgi-20230131_def.xml Edgar Link unprocessable
0001477932-23-001521-index-headers.html Edgar Link pending
0001477932-23-001521-index.html Edgar Link pending
0001477932-23-001521.txt Edgar Link pending
0001477932-23-001521-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gmgi-20230131.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gmgi-20230131_cal.xml Edgar Link unprocessable
gmgi_10q.htm Edgar Link pending
gmgi_10qimg2.jpg Edgar Link pending
gmgi_ex311.htm Edgar Link pending
gmgi_ex312.htm Edgar Link pending
gmgi_ex321.htm Edgar Link pending
gmgi_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
gmgi-20230131_pre.xml Edgar Link unprocessable
gmgi_10q_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending